How we set up the UK’s first clopidogrel genomics testing system Specialist clinical pharmacist Alex Matos explains how he has been implementing pharmacogenomics in daily use on the acute stroke ward.…
Epilepsy: management An overview of commonly used anti-seizure medicines as well as guidance on their initiation, adding on and withdrawal.…
Epilepsy: symptoms and diagnosis An overview of epilepsy, including seizure types, associated risks and diagnosis.…
Multiple sclerosis: disease-modifying therapies An overview of the available evidence for each disease-modifying therapy for multiple sclerosis, when they are indicated, as well as each stage of patient care.…
Racial and ethnic disparities in mental health care An overview of evident racial inequalities in mental health treatments across all ages, as well as discussion on how pharmacists can challenge and/or prevent this imbalance.…
Headache: a visual guide Headache is among the most common neurological reasons for A&E attendance, but most cases can be treated in primary care. This infographic provides a visual overview of the main types of headache.…
Pharmacist-led atrial fibrillation case finding programme prevents an estimated 90 strokes A pharmacist-led programme to identify patients with atrial fibrillation may have prevented up to 90 AF-related strokes across 23 clinical commissioning group areas, NHS England has said.…
One in ten hospital trusts have been asked to approve unlicensed cannabis-based medicinal prescriptions Around 10% of hospital trusts have received requests for prescriptions of unlicensed cannabis-based medical products.…
Siponimod now recommended for patients with secondary progressive MS Updated draft guidance from the National Institute for Health and Care Excellence has recommended siponimod for the treatment of secondary progressive multiple sclerosis.…
Cannabis-based Epidyolex approved for NHS use in Scotland Epidyolex, a cannabidiol medicine for severe epilepsy in children, has been approved for use on the NHS in Scotland.…
